CellSafe en Dynasty Castle Investments Limited ondertekenden distributieovereenkomst voor LAMPlexTM RT-qLAMP COVID-19-detectietest
HONG KONG– (BUSINESS WIRE) – CellSafe, een specialist in het ontwikkelen van diagnostiek in de Republiek Korea en Dynasty Castle Investments Limited, een in Hongkong gevestigd bedrijf dat gespecialiseerd is in de aanschaf, distributie en levering van medische benodigdheden, hebben vandaag aangekondigd dat ze hebben getekend een exclusieve distributieovereenkomst voor Portugal en 6 Afrikaanse landen voor de verkoop en distributie van LAMPlexTM RT-qLAMP COVID-19 Detection Assay, real-time reverse transcription loop-gemedieerde isothermische amplificatie (LAMP) technologie-gebaseerde kit die het nieuwe coronavirus kan detecteren binnen 25 minuten.
DCI heeft het recht om deze klinisch bewezen, betrouwbare FAST moleculaire diagnosekit in dergelijke landen te leveren in samenwerking met zijn lokale distributeurs. Omdat deze wereldwijde pandemie over de hele wereld woedt, heeft CellSafe samengewerkt met het Armed Forces Medical Research Institute, Republiek Korea om de LAMPlexTM RT-qLAMP COVID-19-detectietest te ontwikkelen en te lanceren.
CellSafe and Dynasty Castle Investments Limited Signed Distribution Agreement for LAMPlexTM RT-qLAMP COVID-19 Detection Assay
HONG KONG–(BUSINESS WIRE)– CellSafe, a specialist in developing diagnostics located at the Republic of Korea and Dynasty Castle Investments Limited, a Hong Kong based company specializing in the procurement, distribution and delivery of medical supplies, today announced that they have signed an exclusive distribution agreement for Portugal and 6 African countries for the sale and distribution of LAMPlexTM RT-qLAMP COVID-19 Detection Assay, real-time reverse transcription loop-mediated isothermal amplification (LAMP) technology-based kit which can detect the novel corona virus within 25 minutes.
DCI has the rights to supply this clinically proven, reliable FAST molecular diagnostic kit in such countries in partnership with its local distributors. As this global pandemic is raging across the world, CellSafe has cooperated with Armed Forces Medical Research Institute, Republic of Korea to develop and launch LAMPlexTM RT-qLAMP COVID-19 Detection Assay.
“This unprecedented pandemic is affecting our lives everywhere. So we felt the urgency of developing LAMP detection kit which is very fast and with similar sensitivity and specificity like RT-PCR kits. We believe our LAMP kit will play crucial roles in preventing the spread of corona virus, in particular, at airports, ports, stadiums where fast detection of corona virus is required,” said Jae Jin HAN, CEO of CellSafe.
“We are very pleased to work with CellSafe to launch this FAST LAMP COVID-19 Detection Kit and are happy about the sensitivity and specificity of their kit. We are looking forward to expanding our partnership further,” commented DCI Chief Medical Officer, Dr. Rav Naik.
About LAMPlexTM RT-qLAMP COVID-19 Detection Assay
LAMPlexTM RT-qLAMP COVID-19 Detection Assay is an in vitro diagnostic medical device for the FAST detection of novel coronavirus 2019-nCoV. This device detects the virus through real-time reverse transcription loop-mediated isothermal amplification with RNA isolated from the samples (human nasopharyngeal & oropharyngeal swabs and sputum) collected from suspected SARS-CoV-2 patients.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200929006179/en/
Contacts
About CellSafe Co., Ltd.
Jeong Heum Yeon
Business Director
yeonjh@cells-safe.com
+82-31-285-9958
About Dynasty Castle Investments Limited
Dr. Rav Naik
Chief Medical Officer
ravnaik@aol.com
+44-7733-222888